Robert A Brodsky Selected Research

Hemoglobinuria

12/2020	Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab.
5/2009	Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Brodsky Research Topics

Disease

46	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023 - 04/2004
37	Hemolysis 10/2023 - 01/2006
21	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 04/2006
20	Aplastic Anemia (Anemia, Hypoplastic) 11/2023 - 03/2002
20	Thrombosis (Thrombus) 10/2023 - 07/2004
14	Atypical Hemolytic Uremic Syndrome 01/2023 - 01/2015
11	Thrombotic Microangiopathies 12/2022 - 01/2015
10	Fatigue 11/2021 - 01/2006
8	Anemia 01/2022 - 02/2008
7	Hemolytic Anemia 11/2021 - 04/2008
7	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 06/2008
6	Infections 04/2022 - 12/2015
6	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 04/2004
6	Bone Marrow Failure Disorders 11/2021 - 06/2009
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 03/2009
5	Neoplasms (Cancer) 12/2022 - 09/2006
5	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 07/2002
5	Thrombotic Thrombocytopenic Purpura 12/2021 - 01/2015
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 01/2019
4	HELLP Syndrome 04/2022 - 05/2016
4	Thrombocytopenia (Thrombopenia) 01/2022 - 02/2008
4	Stroke (Strokes) 01/2022 - 01/2019
4	Chronic Disease (Chronic Diseases) 11/2021 - 09/2006
4	Muscle Hypotonia (Hypotonia) 11/2017 - 03/2014
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2014 - 05/2004
4	Diffuse Esophageal Spasm (Esophageal Spasm) 06/2011 - 01/2006
3	Myasthenia Gravis 01/2020 - 03/2005
3	Protein Deficiency 10/2014 - 01/2009
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2014 - 04/2004
3	Multiple Sclerosis 02/2012 - 03/2005
3	Erectile Dysfunction 03/2008 - 01/2006
2	COVID-19 01/2022 - 10/2020
2	Thromboembolism 01/2022 - 12/2007
2	Myocardial Infarction 01/2022 - 12/2021
2	Hypertension (High Blood Pressure) 12/2021 - 01/2019
2	Chronic Renal Insufficiency 12/2021 - 07/2013
2	Leukemia 01/2021 - 03/2013
2	Pain (Aches) 01/2021 - 01/2006
2	Hemoglobinuria 12/2020 - 05/2009
2	Multiple Myeloma 11/2017 - 05/2003
2	Disease Progression 01/2016 - 05/2005
2	Seizures (Absence Seizure) 10/2014 - 03/2014
2	Burkitt Lymphoma (Burkitt's Lymphoma) 03/2013 - 04/2009
2	Relapsing-Remitting Multiple Sclerosis 02/2012 - 08/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2010 - 01/2003
2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 05/2009 - 02/2006
2	Pancytopenia 08/2008 - 05/2005
1	Livedoid Vasculopathy 11/2023
1	Hemoglobinopathies 11/2023
1	Cerebral Infarction 01/2023

Drug/Important Bio-Agent (IBA)

46	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 03/2002
43	Complement System Proteins (Complement)IBA 11/2023 - 04/2004
27	eculizumab FDA Link 01/2023 - 09/2006
13	Complement Inactivating AgentsIBA 11/2021 - 09/2006
13	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2021 - 05/2005
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2007
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020 - 09/2006
6	GPI-Linked ProteinsIBA 01/2017 - 04/2004
6	Monoclonal AntibodiesIBA 01/2017 - 04/2004
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2022 - 05/2005
5	Hemoglobins (Hemoglobin)IBA 01/2013 - 01/2006
3	thiamine triphosphorate (TTP)IBA 01/2023 - 06/2015
3	EnzymesIBA 04/2022 - 05/2016
3	AutoantibodiesIBA 01/2022 - 01/2015
3	ravulizumabIBA 03/2021 - 12/2020
3	Antiphospholipid AntibodiesIBA 01/2021 - 01/2019
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 11/2012
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 11/2012
3	Rituximab (Mabthera)FDA Link 12/2015 - 04/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2011 - 10/2007
2	Complement C5 (Complement 5)IBA 01/2023 - 07/2022
2	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 03/2011
2	fludarabineIBA 09/2022 - 11/2012
2	Complement Factor D (Factor D)IBA 01/2022 - 01/2017
2	AntigensIBA 01/2022 - 10/2019
2	pegcetacoplanIBA 01/2022 - 11/2020
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 11/2021
2	TESIBA 01/2022 - 07/2013
2	danicopanIBA 11/2021 - 01/2017
2	AntibodiesIBA 01/2020 - 01/2008
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 11/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 11/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2016 - 05/2005
2	Immunoglobulin M (IgM)IBA 11/2015 - 01/2015
2	proaerolysinIBA 08/2012 - 04/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 04/2009
1	thymoglobulin FDA Link 11/2023
1	Adenosine Diphosphate (ADP)IBA 10/2023
1	Thrombin FDA Link 01/2023
1	trans-crotonin (CTN)IBA 09/2022

Therapy/Procedure

30	Therapeutics 01/2023 - 03/2005
23	Transplantation 11/2023 - 05/2003
21	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2023 - 03/2002
4	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2003
3	Drug Therapy (Chemotherapy) 12/2022 - 01/2003
3	Salvage Therapy 09/2022 - 05/2004
3	Stem Cell Transplantation 08/2014 - 01/2003
2	Homologous Transplantation 12/2014 - 04/2006
2	Erythrocyte Transfusion 03/2008 - 10/2007
2	Immunotherapy 01/2008 - 03/2005